Aligos Therapeutics, Inc. (NASDAQ:ALGS) Short Interest Update
Aligos Therapeutics, Inc. (NASDAQ:ALGS – Get Free Report) was the target of a large decrease in short interest in May. As of May 15th, there was short interest totalling 640,200 shares, a decrease of 23.4% from the April 30th total of 835,700 shares. Currently, 15.2% of the company’s stock are sold short. Based on an […]
Aligos Therapeutics, Inc. (NASDAQ:ALGS – Get Free Report) was the target of a large decrease in short interest in May. As of May 15th, there was short interest totalling 640,200 shares, a decrease of 23.4% from the April 30th total of 835,700 shares. Currently, 15.2% of the company’s stock are sold short. Based on an […]
